Cargando...

Non-Myeloablative Conditioning for Second Hematopoietic Cell Transplantation for Graft Failure in Patients with Non-Malignant Disorders: A prospective study and review of the literature

Allogeneic hematopoietic cell transplantation (HCT) effectively treats seeveral non-malignant disorders (NMD) such as selected lysosomal disorders, cerebral adrenoleukodystrophy, and hemoglobinopathies. However, rates of graft failure (GF) in non-malignant populations exceed those of patients with m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Bone Marrow Transplant
Main Authors: Mallhi, Kanwaldeep, Orchard, Paul J., Miller, Weston P., Cao, Qing, Tolar, Jakub, Lund, Troy C.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5604220/
https://ncbi.nlm.nih.gov/pubmed/28092353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2016.356
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!